Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumab
Alzheimer's & Dementia: Translational Research & Clinical Interventions（2015）
摘要
ClinicalTrials.gov identifier: NCT00575055 and NCT00574132.
更多查看译文
关键词
ADAS-cog/11,Bapineuzumab,Alzheimer's disease,Disease progression model
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要